Is a Correction Looming Ahead for Reata Pharmaceuticals Inc. (RETA)
Reata Pharmaceuticals Inc. (NASDAQ:RETA) went down by -5.63% from its latest closing price compared to the recent 1-year high of $153.41. The company’s stock price has collected 1.27% of gains in the last five trading sessions. Press Release reported 14 hours ago that CNS Pharmaceuticals Receives
Source: newsheater.com